Summary
Using tissue taken post mortem from patients with neuropathologically confirmed Huntington's disease and a series of appropriate control cases, GABA, dopamine and homovanillic acid were measured in the caudate nucleus and the putamen. The previously reported loss of GABA in Huntington's disease was confirmed, while no change in dopamine concentrations and a loss of homovanillic acid in these striatal regions were observed. This loss could not be explained on the basis of agonal state or previous drug treatment.
This is a preview of subscription content, log in via an institution to check access.
References
Bernheimer, H., Hornykiewicz, O.: Brain amines in Huntington's chorea. In: Advances in Neurology (Barbeau, A., Chase, T. N., Paulson, G. W., eds.), Vol. 1, pp. 525–531. New York: Raven Press. 1973.
Bird, E. D., Iversen, L. L.: Huntington's chorea—post mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia. Brain97, 457–472 (1974).
Chase, E. N.: Biochemical and pharmacological studies of monoamines in Huntington's chorea. In: Advances in Neurology (Barbeau, A., Chase, T. N., Paulson, G. W., eds.), Vol. 1, pp. 533–542. New York: Raven Press. 1973.
Crow, T. J., Baker, H. F., Cross, A. J., Joseph, M. H., Lofthouse, R., Longden, A., Owen, F., Riley, J., Glover, V., Killpack, W. S.: Monoamine mechanisms in chronic schizophrenia: post mortem neurochemical findings. Brit. J. Psychiat.134, 249–256 (1979).
Crow, T. J., Owen, F., Cross, A. J., Ferrier, N., Johnstone, E. C., McCreadie, R. M., Owens, D. G. C., Poulter, M.: Neurotransmitter enzymes and receptors in post mortem brain in schizophrenia: evidence that an increase in D2 dopamine receptors is associated with the type I syndrome. In: Transmitter Biochemistry of Human Brain Tissue (Riederer, P., Usdin, E., eds.), pp. 85–96. London: Macmillan. 1981.
Curzon, G., Gumpert, J., Sharpe, D.: Amine metabolites in the cerebrospinal fluid in Huntington's chorea. J. Neurol. Neurosurg. Psychiat.35, 514–519 (1972).
Curzon, G.: CSF Homovanillic acid: an index of dopaminergic activity. In: Advances in Neurology (Calne, D., Chase, T. N., Barbeau, A., eds.), Vol. 9, pp. 349–357. New York: Raven Press. 1975.
Kravitz, E. A., Potter, D. D.: A further study of the distribution of aminobutyric acid between excitatory and inhibitory axons of the lobster. J. Neurochem.12, 323–328 (1965).
Melamed, E., Hefti, F., Bird, E. D.: Huntington's chorea is not associated with hyperactivity of nigrostriatal dopaminergic neurons: studies in post mortem tissues and in rats with kainic acid lesions. Neurology32, 640–644 (1982).
Perry, T. L., Hansen, S., Kloster, M.: Huntington's chorea: deficiency of γ-aminobutyric acid in brain. New Engl. J. Med.288, 337–342 (1973).
Spokes, E. G. S.: An analysis of factors influencing measurements of dopamine, noradrenaline, glutamate decarboxylase and choline acetylase in human post mortem brain tissue. Brain102, 333–346 (1979).
Spokes, E. G. S.: Neurochemical alterations in Huntington's chorea. Brain103, 179–210 (1980).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Reynolds, G.P., Garrett, N.J. Striatal dopamine and homovanillic acid in Huntington's Disease. J. Neural Transmission 65, 151–155 (1986). https://doi.org/10.1007/BF01256491
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01256491